ImCheck Therapeutics

France
Missy, Normandy, France, 13009

Company profile

ImCheck Therapeutics company profile

ImCheck Therapeutics is a developer of immunomodulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric and ovarian cancer cells, and other solid tumors.

Business identity

Phone number
+33 4 13 96 14 90
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
13009
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
7
Total equity funding
$183.3M
Last funding
Grant / $22.4M / 2024-08-29
Last equity funding
Series C / $100M
Investors
19
Lead investors
9
Founders
3
Articles
62
Exited on
2025-10-22

Founders and investors

Founders

Alem TrunehBenjamin CharlesDaniel Olive

Lead investors

Andera PartnersBoehringer Ingelheim Venture FundBpifranceEarlybird Venture CapitalFrance 2030Idinvest PartnersKurma PartnersPfizer Venture InvestmentsPureos Bioventures

Investors

Andera PartnersBoehringer Ingelheim Venture FundBpifranceEQT Life SciencesKurma Partners